Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:34481949

A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide.

Eva Pauwels · Claudia Rutz · Becky Provinciael · Joren Stroobants · Dominique Schols · Enno Hartmann · Eberhard Krause · Heike Stephanowitz · Ralf Schülein · Kurt Vermeire

Molecular & cellular proteomics : MCP · 2021 doi:10.1016/j.mcpro.2021.100144

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:34481949
kind
science-record
content_hash
sha256:88aedb74c15b1cdb64ccbd152eab869c454eaee3f1b98103f6dca77e0aa4e087
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:50Z
updated_at
2026-11-01T21:26:09Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide.
doi
10.1016/j.mcpro.2021.100144
pmid
34481949
authors array · 10 items
[0]
Eva Pauwels
[1]
Claudia Rutz
[2]
Becky Provinciael
[3]
Joren Stroobants
[4]
Dominique Schols
[5]
Enno Hartmann
[6]
Eberhard Krause
[7]
Heike Stephanowitz
[8]
Ralf Schülein
[9]
Kurt Vermeire
journal
Molecular & cellular proteomics : MCP
year
2021
abstract
Cyclotriazadisulfonamide (CADA) inhibits the cotranslational translocation of type I integral membrane protein human CD4 (huCD4) across the endoplasmic reticulum in a signal peptide (SP)-dependent way. Previously, sortilin was identified as a secondary substrate for CADA but showed reduced CADA sensitivity as compared with huCD4. Here, we performed a quantitative proteomic study on the crude membrane fraction of human T-cells to analyze how many proteins are sensitive to CADA. To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. In line with our previous reports, our current proteomic analysis (data available via ProteomeXchange with identifier PXD027712) demonstrated that only a very small subset of proteins is depleted by CADA. Our data also confirmed that cellular expression of both huCD4 and sortilin are affected by CADA treatment of SUP-T1 cells. Furthermore, three additional targets for CADA are identified, namely, endoplasmic reticulum lectin 1 (ERLEC1), inactive tyrosine-protein kinase 7 (PTK7), and DnaJ homolog subfamily C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7, and DNAJC3 protein expression validated susceptibility of these substrates to CADA, although with varying degrees of sensitivity. Additional cell-free in vitro translation/translocation data demonstrated that the new substrates for CADA carry cleavable SPs that are targets for the cotranslational translocation inhibition exerted by CADA. Thus, our quantitative proteomic analysis demonstrates that ERLEC1, PTK7, and DNAJC3 are validated additional substrates of CADA; however, huCD4 remains the most sensitive integral membrane protein for the endoplasmic reticulum translocation inhibitor CADA. Furthermore, to our knowledge, CADA is the first compound that specifically interferes with only a very small subset of SPs and does not affect signal anchor sequences.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712.
kind
methodological
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:34481949
locator
sections[0] "Abstract" paragraph 1
quote
To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4.
[1] object · 3 fields
asset
source:pmid:34481949
locator
sections[22] "Data Availability" paragraph 2
quote
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34481949
locator
sections[22] "Data Availability" paragraph 2
quote
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:34481949
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD027712
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD027712
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:34481949
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1016/j.mcpro.2021.100144
sha256
sha256:0b6937ee827ba6b3a30a3c72f3a84a168e82fabbdd41a8644df44f2a1d5d856a
bytes
73861
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1016/j.mcpro.2021.100144
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8477212
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD027712
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD027712
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD027712
version
null
note
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
A proteomic study on the membrane protein fraction of T cells confirms high substrate selectivity for the ER translocation inhibitor cyclotriazadisulfonamide
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:34481949:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:95e0c6555dd7888b71beccc646228fbef16b1d0f6584e5ad43a3b8470451d59b
bytes
1370
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#tbl1
version
null
note
Potential CADA-affected SILAC targets selected for validation
structure object · 5 fields
pmcid
PMC8477212
section_index
17
section_title
CADA Sensitivity of Integral Membrane Proteins of SUP-T1 Cells
row_count
6
column_count
6
table object · 8 fields
label
Table 1
caption
Potential CADA-affected SILAC targets selected for validation
rows array · 6 items
[0] array · 6 items
[0]
UniProt_ID
[1]
Protein
[2]
Function
[3]
Cellular localization
[4]
Ratio H/La
[5]
Ratio L/Hb
[1] array · 6 items
[0]
P01730
[1]
Human T-cell surface glycoprotein CD4 (cluster of differentiation 4)
[2]
Major histocompatibility complex class-II antigen/T-cell coreceptor
[3]
Cell surface
[4]
3.63
[5]
3.61
[2] array · 6 items
[0]
Q13308
[1]
Human PTK7, CCK-4 (colon carcinoma kinase 4)
[2]
Inactive tyrosine kinase involved in Wnt signaling pathway, both the noncanonical (Wnt/planar cell polarity signaling) and the canonical pathway
[3]
Cell surface
[4]
2.39
[5]
2.49
[3] array · 6 items
[0]
Q13217
[1]
Human DNAJC3, ERdj6 (endoplasmic reticulum DNA J domain–containing protein 6)
[2]
Involved in the unfolded protein response (UPR) during ER stress
[3]
ER lumen
[4]
2.16
[5]
2.93
[4] array · 6 items
[0]
Q99523
[1]
Sortilin, NTR3 (human neurotensin receptor 3)
[2]
Sorting receptor in the Golgi compartment, required for protein transport from the Golgi apparatus. Also acts as a receptor for neurotensin
[3]
Nucleus, ER, Golgi, and cell surface
[4]
2.07
[5]
3.48
[5] array · 6 items
[0]
Q96DZ1
[1]
Human ERLEC1, XTP3B (XTP3-transactivated gene B protein)
[2]
Probable lectin that binds selectively to improperly folded lumenal proteins. May function in ER quality control and ERAD
[3]
ER lumen
[4]
2.00
[5]
2.11
locator
section[17]/table-wrap[1]#tbl1
gaps array · 2 items
[0]
asset:data:geo:PXD027712 not downloaded
[1]
asset:data:geo:PXD027712 licence not read
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
Stable isotope labeling by amino acids in cell culture (SILAC) combined with quantitative mass spectrometry
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
reordered
quote
To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocking_axis
method
blocked_on
method:not_determinable
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (Stable isotope labeling by amino acids in cell culture (SILAC) combined with quantitative mass spectrometry), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD027712
resolved_accessions array · 1 item
[0]
PXD027712
statements array · 1 item
[0]
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.
basis
The paper names PXD027712 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 3 items
[0]
source:pmid:34481949
[1]
data:geo:PXD027712
[2]
asset:table:pmid:34481949:1
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD027712
gaps array · 1 item
[0]
method:not_determinable
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:34:24Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
60066
completion_tokens
1192
cached_tokens
784
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:34481949
type
paper
label
pmid:34481949
[1] object · 3 fields
id
source:pmid:34481949
type
manuscript
label
PMID 34481949 full text
[2] object · 3 fields
id
data:geo:PXD027712
type
dataset
label
GEO PXD027712
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:34481949
type
paper
label
pmid:34481949
[1] object · 3 fields
id
source:pmid:34481949
type
manuscript
label
PMID 34481949 full text
[2] object · 3 fields
id
data:geo:PXD027712
type
dataset
label
GEO PXD027712
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-34481949
type
extraction
used array · 1 item
[0]
source:pmid:34481949
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD027712
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD027712
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:34481949
parent_hash
sha256:5f13a7016ea8428edb60114a2339dd1a1137f582ed2333a5f3416e2f566e90c8
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:PXD027712 licence not read
[1]
asset:data:geo:PXD027712 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 4 items
[0] object · 11 fields
role
data_generation
definition_id
western_blot
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
DnaJ homolog subfamily C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7,
[1]
both experiments. For the flow cytometry and Western blotting validation experiments, at least three indep
[2]
tential CADA Targets With Flow Cytometry and Western Blotting To confirm the potential CADA hits from the
[3]
experiments. Values are mean ± SD; n ≥ 3. B, Western blot images of cell lysates from nontransfected (
order_basis
paper_text_order:1351
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
flow_cytometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
family C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7, and DNAJC3 protein
[1]
higher than 2.0 in both experiments. For the flow cytometry and Western blotting validation experiments,
[2]
sion Analysis of Potential CADA Targets With Flow Cytometry and Western Blotting To confirm the potentia
[3]
treated or DMSO-treated SUP-T1 cells. First, flow cytometry was used to analyze the natural cell surface
order_basis
paper_text_order:1367
id
assay:2
[2] object · 11 fields
role
data_generation
definition_id
cell_culture
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.77
evidence array · 1 item
[0]
were performed using a different passage of cultured cells. For the in vitro translation/transloc
order_basis
paper_text_order:4729
id
assay:3
[3] object · 11 fields
role
data_generation
definition_id
transfection
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
of huCD4, SORT, PTK7, ERLEC1, and DNAJC3 in transfected cells.A, concentration–response curves of CA
[1]
5, SORT-V5, PTK7-V5, ERLEC1-V5, or DNAJC3-V5 transfected HEK293T cells treated for 24 h with differen
[2]
for huCD4, SORT, PTK7, ERLEC1, and DNAJC3 in transfected HEK293T cells. Samples from (B) were quantif
[3]
proteins SORT and huCD4. HEK293T cells were transfected with the plasmids, treated with increasing c
order_basis
paper_text_order:6194
id
assay:4
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34481949", "kind": "science-record", "revision": 6, "content_hash": "sha256:88aedb74c15b1cdb64ccbd152eab869c454eaee3f1b98103f6dca77e0aa4e087", "created_at": "2026-11-01T15:41:50Z", "updated_at": "2026-11-01T21:26:09Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide.", "doi": "10.1016/j.mcpro.2021.100144", "pmid": "34481949", "authors": ["Eva Pauwels", "Claudia Rutz", "Becky Provinciael", "Joren Stroobants", "Dominique Schols", "Enno Hartmann", "Eberhard Krause", "Heike Stephanowitz", "Ralf Schülein", "Kurt Vermeire"], "journal": "Molecular & cellular proteomics : MCP", "year": 2021, "abstract": "Cyclotriazadisulfonamide (CADA) inhibits the cotranslational translocation of type I integral membrane protein human CD4 (huCD4) across the endoplasmic reticulum in a signal peptide (SP)-dependent way. Previously, sortilin was identified as a secondary substrate for CADA but showed reduced CADA sensitivity as compared with huCD4. Here, we performed a quantitative proteomic study on the crude membrane fraction of human T-cells to analyze how many proteins are sensitive to CADA. To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. In line with our previous reports, our current proteomic analysis (data available via ProteomeXchange with identifier PXD027712) demonstrated that only a very small subset of proteins is depleted by CADA. Our data also confirmed that cellular expression of both huCD4 and sortilin are affected by CADA treatment of SUP-T1 cells. Furthermore, three additional targets for CADA are identified, namely, endoplasmic reticulum lectin 1 (ERLEC1), inactive tyrosine-protein kinase 7 (PTK7), and DnaJ homolog subfamily C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7, and DNAJC3 protein expression validated susceptibility of these substrates to CADA, although with varying degrees of sensitivity. Additional cell-free in vitro translation/translocation data demonstrated that the new substrates for CADA carry cleavable SPs that are targets for the cotranslational translocation inhibition exerted by CADA. Thus, our quantitative proteomic analysis demonstrates that ERLEC1, PTK7, and DNAJC3 are validated additional substrates of CADA; however, huCD4 remains the most sensitive integral membrane protein for the endoplasmic reticulum translocation inhibitor CADA. Furthermore, to our knowledge, CADA is the first compound that specifically interferes with only a very small subset of SPs and does not affect signal anchor sequences.", "claims": [{"id": "claim-method", "statement": "To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34481949", "locator": "sections[0] \"Abstract\" paragraph 1", "quote": "To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4."}, {"asset": "source:pmid:34481949", "locator": "sections[22] \"Data Availability\" paragraph 2", "quote": "The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34481949", "locator": "sections[22] \"Data Availability\" paragraph 2", "quote": "The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34481949"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD027712"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD027712"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34481949", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1016/j.mcpro.2021.100144", "sha256": "sha256:0b6937ee827ba6b3a30a3c72f3a84a168e82fabbdd41a8644df44f2a1d5d856a", "bytes": 73861, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1016/j.mcpro.2021.100144", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8477212", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD027712", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD027712", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD027712", "version": null, "note": "The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "A proteomic study on the membrane protein fraction of T cells confirms high substrate selectivity for the ER translocation inhibitor cyclotriazadisulfonamide", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:34481949:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:95e0c6555dd7888b71beccc646228fbef16b1d0f6584e5ad43a3b8470451d59b", "bytes": 1370, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#tbl1", "version": null, "note": "Potential CADA-affected SILAC targets selected for validation", "structure": {"pmcid": "PMC8477212", "section_index": 17, "section_title": "CADA Sensitivity of Integral Membrane Proteins of SUP-T1 Cells", "row_count": 6, "column_count": 6}, "table": {"label": "Table 1", "caption": "Potential CADA-affected SILAC targets selected for validation", "rows": [["UniProt_ID", "Protein", "Function", "Cellular localization", "Ratio H/La", "Ratio L/Hb"], ["P01730", "Human T-cell surface glycoprotein CD4 (cluster of differentiation 4)", "Major histocompatibility complex class-II antigen/T-cell coreceptor", "Cell surface", "3.63", "3.61"], ["Q13308", "Human PTK7, CCK-4 (colon carcinoma kinase 4)", "Inactive tyrosine kinase involved in Wnt signaling pathway, both the noncanonical (Wnt/planar cell polarity signaling) and the canonical pathway", "Cell surface", "2.39", "2.49"], ["Q13217", "Human DNAJC3, ERdj6 (endoplasmic reticulum DNA J domain–containing protein 6)", "Involved in the unfolded protein response (UPR) during ER stress", "ER lumen", "2.16", "2.93"], ["Q99523", "Sortilin, NTR3 (human neurotensin receptor 3)", "Sorting receptor in the Golgi compartment, required for protein transport from the Golgi apparatus. Also acts as a receptor for neurotensin", "Nucleus, ER, Golgi, and cell surface", "2.07", "3.48"], ["Q96DZ1", "Human ERLEC1, XTP3B (XTP3-transactivated gene B protein)", "Probable lectin that binds selectively to improperly folded lumenal proteins. May function in ER quality control and ERAD", "ER lumen", "2.00", "2.11"]], "row_count": 6, "column_count": 6, "numeric_cells": 19, "header_rows": 1, "locator": "section[17]/table-wrap[1]#tbl1"}}], "gaps": ["asset:data:geo:PXD027712 not downloaded", "asset:data:geo:PXD027712 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "Stable isotope labeling by amino acids in cell culture (SILAC) combined with quantitative mass spectrometry", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "reordered", "quote": "To screen for these proteins, we employed stable isotope labeling by amino acids in cell culture technique in combination with quantitative MS on CADA-treated human T-lymphoid SUP-T1 cells expressing high levels of huCD4. The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (Stable isotope labeling by amino acids in cell culture (SILAC) combined with quantitative mass spectrometry), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD027712"], "resolved_accessions": ["PXD027712"], "statements": ["The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (80, 81, 82) partner repository with the dataset identifier PXD027712. All validating data by various biological and cell-free in vitro experiments are contained within the article."], "basis": "The paper names PXD027712 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:34481949", "data:geo:PXD027712", "asset:table:pmid:34481949:1"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD027712"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:34:24Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 60066, "completion_tokens": 1192, "cached_tokens": 784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34481949", "type": "paper", "label": "pmid:34481949"}, {"id": "source:pmid:34481949", "type": "manuscript", "label": "PMID 34481949 full text"}, {"id": "data:geo:PXD027712", "type": "dataset", "label": "GEO PXD027712"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34481949", "type": "paper", "label": "pmid:34481949"}, {"id": "source:pmid:34481949", "type": "manuscript", "label": "PMID 34481949 full text"}, {"id": "data:geo:PXD027712", "type": "dataset", "label": "GEO PXD027712"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34481949", "type": "extraction", "used": ["source:pmid:34481949"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD027712", "type": "accession_resolution", "used": ["data:geo:PXD027712"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34481949", "parent_hash": "sha256:5f13a7016ea8428edb60114a2339dd1a1137f582ed2333a5f3416e2f566e90c8", "fork_of": null, "generation": 5}, "gaps": ["asset:data:geo:PXD027712 licence not read", "asset:data:geo:PXD027712 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "western_blot", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["DnaJ homolog subfamily C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7,", "both experiments. For the flow cytometry and Western blotting validation experiments, at least three indep", "tential CADA Targets With Flow Cytometry and Western Blotting To confirm the potential CADA hits from the", "experiments. Values are mean ± SD; n ≥ 3. B, Western blot images of cell lysates from nontransfected ("], "order_basis": "paper_text_order:1351", "id": "assay:1"}, {"role": "data_generation", "definition_id": "flow_cytometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["family C member 3 (DNAJC3). Western blot and flow cytometry analysis of ERLEC1, PTK7, and DNAJC3 protein", "higher than 2.0 in both experiments. For the flow cytometry and Western blotting validation experiments,", "sion Analysis of Potential CADA Targets With Flow Cytometry and Western Blotting To confirm the potentia", "treated or DMSO-treated SUP-T1 cells. First, flow cytometry was used to analyze the natural cell surface"], "order_basis": "paper_text_order:1367", "id": "assay:2"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.77, "evidence": ["were performed using a different passage of cultured cells. For the in vitro translation/transloc"], "order_basis": "paper_text_order:4729", "id": "assay:3"}, {"role": "data_generation", "definition_id": "transfection", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["of huCD4, SORT, PTK7, ERLEC1, and DNAJC3 in transfected cells.A, concentration–response curves of CA", "5, SORT-V5, PTK7-V5, ERLEC1-V5, or DNAJC3-V5 transfected HEK293T cells treated for 24 h with differen", "for huCD4, SORT, PTK7, ERLEC1, and DNAJC3 in transfected HEK293T cells. Samples from (B) were quantif", "proteins SORT and huCD4. HEK293T cells were transfected with the plasmids, treated with increasing c"], "order_basis": "paper_text_order:6194", "id": "assay:4"}]}